BAI Announces 2022 Global Innovation Award Finalists
15.11.2022 22:40:00 EET | Business Wire | Press release
BAI announced the finalists for the 12th Annual BAI Global Innovation Awards, the financial services industry’s leading innovation honor, celebrating organizational achievements. These 27 global trailblazers have successfully designed and delivered innovations that positively improved customer relationships, fostered organizational changes and served their communities. In addition to innovations related to retail and commercial products, digital transformation, community, and organization processes, the finalists represent current themes related to fraud and security, HR and talent development, diversity and inclusion, and ESG.
The 2022 BAI Global Innovation Award finalists are:
Banco Popular (Puerto Rico): Talent Lab & Skills Accelerator
Bank of America (USA): Bank of America Security Center
BankiFi (USA): Open Banking API and Embedded Banking Platform for Businesses
BMO (USA): True Name
DenizBank (Turkey): Technology and Start-up Loans in Agriculture
Dreams Technology (United Kingdom): Dreams ESG Innovation
Fifth Third Bank (USA): Customer Recommendation Engine
FNB (South Africa): FNB Connect
Fonbulucu (Turkey): Fully Integrated Investment Ecosystem
Growsari (Philippines): GROWSARI.com - Powering the Digital Economy of the Philippines
JUMO (South Africa): Core & Unify
Kolleno (United Kingdom): Kolleno AR Platform
Money Management International, Inc (USA): Project Porchlight by MMI
MVB Bank (USA): Onboarding Fintechs Better, Faster, Stronger…the Victor (ad)Vantage
Oportun (USA): Digit by Oportun
OppZo (USA): Democratizing Access to Affordable Working Capital Loans
Payten Technology Inc. (Turkey): Paratika Crowdfunding e-Payment Project
Quilo (USA): Fully Digital Real-Time Syndication Platform
SoLo Funds (USA): SoLo Community Finance Platform
Standard Bank (South Africa): Trader Direct
Standard Bank (South Africa): OneFarm Share
Themis (USA): Making Compliance Easy and Reliable for Banks and Fintechs
Theta Lake (USA): Utilizing AI to Scale Data Security, Risk Detection and Compliance Supervision
TIAA (USA): TIAA Phone Authentication Risk Management (PARM)
Umoja Labs (USA): Building Payment Rails to Enable Universal Access to Affordable Digital Financial Services
Union Bank of India (India): Union Prerna
Yabx Technologies (Netherlands): Simplifying Financial Access, Control and Choice to the Underbanked
Zilch (United Kingdom): Zilch Technology: Financial Services Technology Innovation
“These 27 companies reflect how financial services leaders are bringing original and creative solutions to positively impact their business, customers and other stakeholders,” said Amy Radin, financial services innovation executive, award-winning author, and lead judge of the 2022 BAI Global Innovation Awards.
The winners will be announced in December 2022. To learn more please visit BAI Global Innovation Awards.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221115006381/en/
Contact information
MEDIA CONTACT:
Kendall Carwile
William Mills Agency
678-781-7224
kendall@williammills.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Linnea Achieves CEP Certification for Cannabidiol Isolate3.3.2026 09:25:00 EET | Press release
Linnea is proud to announce that its Cannabidiol (CBD) Isolate has been granted a Certificate of Suitability to the European Pharmacopoeia (CEP). The CEP serves to attest that the quality of an active pharmaceutical ingredient (API) is adequately controlled by the monographs of the European Pharmacopoeia, ensuring its safety, quality and conformity for use in medicinal products in Europe. Issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM), the CEP represents an independent validation of consistency, safety, and regulatory compliance for the European market. This consequently simplifies the marketing authorization (MA) process for new medicines, as a detailed evaluation of the active substance by regulatory authorities is not required. This milestone represents a significant achievement for the company and reinforces its commitment to delivering consistent and high-quality cannabinoid ingredients. The certification provides customers and partners with as
Quectel Expands Small Cell Antennas Portfolio With Five New Products3.3.2026 09:00:00 EET | Press release
Quectel Wireless Solutions, a global end-to-end IoT solutions provider, has introduced five new small cell antennas to add further functionality and provide greater flexibility and choice for customers designing and implementing small cell deployments. The new antennas bring an additional range of form factors, mounting options and performance characteristics to the Quectel antenna range. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302915004/en/ Quectel expands small cell antennas portfolio with five new products “Whether you’re looking for an antenna to support critical wireless communications, dense stadium usage scenarios or ultimate capacity, these five new Quectel antennas have been designed to meet your needs,” says David Wei, Antenna Product Head, Quectel Wireless Solutions. “The new antennas augment our already comprehensive range of antennas, bring further choice and add capabilities for developers and enginee
Quectel Introduces FGH200M Wi-Fi HaLow Module for massive IoT Deployments3.3.2026 09:00:00 EET | Press release
Quectel Wireless Solutions, a global end-to-end IoT solutions provider, today announces the launch of the FGH200M long range, low power Wi-Fi HaLow module. Based on the Morse Micro MM8108 chipset and operating in the sub-1GHz license exempt frequency band, the module delivers enhanced penetration and broader coverage, over a range of approximately 1km, while supporting low power consumption and large-scale device connectivity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302200601/en/ Quectel introduces FGH200M Wi-Fi HaLow module for massive IoT deployments The FGH200M module adopts the IEEE 802.11ah wireless networking protocol, also known as Wi-Fi HaLow, operating in the license-exempt Sub-1GHz spectrum. Designed to meet the evolving requirements of IoT connectivity, the FGH200M delivers extended Sub-1GHz signal coverage, enabling reliable device control at distances of up to one kilometer. “We’re excited to unveil th
Meiji Seika Pharma’s Morcamilast (ME3183) was Granted Orphan Medicinal Product Designation by the European Commission for Palmoplantar Pustulosis3.3.2026 03:00:00 EET | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that morcamilast (proposed international nonproprietary name; development code: ME3183), a selective phosphodiesterase-4 (PDE4) inhibitor, has been granted orphan medicinal product designation by the European Commission (EC) for the treatment of palmoplantar pustulosis (PPP). Palmoplantar pustulosis is a chronic inflammatory disease characterized by the development of multiple sterile pustules on the palms and soles. Patients often experience pain and pruritus of the skin, and the condition can be accompanied by nail involvement and joint pain. Because lesions on the palms are visible to others and lesions on the soles can cause pain while walking, daily functioning can be significantly restricted, leading in a substantial reduction in quality of life. PPP has a pathophysiology distinct from psoriasis and pustular psoriasis, and treatment can be challenging, unde
IFF Completed the Divestiture of Soy Crush, Concentrates and Lecithin Businesses2.3.2026 23:15:00 EET | Press release
IFF (NYSE: IFF) today announced that it has successfully completed the previously announced divestiture of its soy crush, concentrates and lecithin businesses to Bunge. This transaction does not include IFF’s soy isolates business. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in taste, scent, food ingredients, health and biosciences, we’re innovating for the future. Every day, we deliver groundbreaking, sustainable solutions that elevate products people love — advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook. © 2026 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved. View source version on businesswire.com: https://www.businesswire.com/news/home/20260302231096/en/
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom